PSNL
PSNL
NASDAQ · Life Sciences Tools & Services

Personalis Inc

$10.33
+0.16 (+1.57%)
As of Jun 23, 2:45 PM ET ·
Financial Highlights (FY 2026)
Revenue
81.73M
Net Income
-95,369,506
Gross Margin
22.6%
Profit Margin
-116.7%
Rev Growth
+2.3%
D/E Ratio
0.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 22.6% 22.6% 34.5% 34.5%
Operating Margin -126.4% -113.8% 8.7% 7.6%
Profit Margin -116.7% -110.9% 7.4% 5.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 81.73M 79.90M 842.44M 788.11M
Gross Profit 18.51M 18.10M 290.48M 271.75M
Operating Income -103,337,330 -90,912,607 73.02M 60.07M
Net Income -95,369,506 -83,902,791 62.65M 45.28M
Gross Margin 22.6% 22.6% 34.5% 34.5%
Operating Margin -126.4% -113.8% 8.7% 7.6%
Profit Margin -116.7% -110.9% 7.4% 5.8%
Rev Growth +2.3% +2.3% +3.3% +14.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 10.87M 10.87M 109.54M 111.95M
Total Equity 541.01M 541.01M 454.92M 451.32M
D/E Ratio 0.02 0.02 0.24 0.25
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -91,547,186 -85,014,493 87.86M 84.18M
Free Cash Flow 62.43M 43.12M